Notch Therapeutics
Timothy Key joined Notch Therapeutics as Director, Business Development after working on the company concept as part of his role at MaRS Innovation (now Toronto Innovation Acceleration Partners). Dr. Key holds a PhD in Microbiology and Immunology from Dalhousie University, and he trained in drug discovery and development of small molecules and biologics at the Center for Drug Research and Development (CDRD) in Vancouver.
This person is not in any teams
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.